Sison, E. A. R., Magoon, D., Li, L., Annesley, C. E., Romagnoli, B., Douglas, G. J., . . . Brown, P. (2015). POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL. Oncotarget.
Chicago Style CitationSison, Edward Allan R., Daniel Magoon, Li Li, Colleen E. Annesley, Barbara Romagnoli, Garry J. Douglas, Gerald Tuffin, Johann Zimmermann, i Patrick Brown. "POL5551, a Novel and Potent CXCR4 Antagonist, Enhances Sensitivity to Chemotherapy in Pediatric ALL." Oncotarget 2015.
Cita MLASison, Edward Allan R., et al. "POL5551, a Novel and Potent CXCR4 Antagonist, Enhances Sensitivity to Chemotherapy in Pediatric ALL." Oncotarget 2015.
Atenció: Aquestes cites poden no estar 100% correctes.